Stereospecific Interaction of Bupivacaine Enantiomers with Lipid Membranes

Background and Objectives: S(−)-Bupivacaine has the pharmacotoxicological advantage over its antipode and racemate. The interaction with lipid membranes was compared between S(−)-, R(+)- and racemic bupivacaine. Methods: The bupivacaine-induced changes in membrane property were determined by turbidity and fluorescence polarization measurements of membrane preparations to which bupivacaine stereoisomers of 1.0-5.0 mmol/L were applied. Liposomal membranes were made of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine without or with cholesterol (5 to 15 mol%), and nerve cell model membranes of 55 mol% different phospholipids and 45 mol% cholesterol. The purity and hydrophobic interaction of bupivacaine were analyzed by reversed-phase high-performance liquid chromatography. Results: Both S(−)- and R(+)-bupivacaine were not different in lowering the phase transition temperature of membrane 1,2-dipalmitoyl-sn-glycero-3-phosphocholine. S(−)-, R(+)- and racemic bupivacaine disordered 100 mol% 1,2-dipalmitoyl-sn-glycero-3-phosphocholine liposomal membranes, although the potency was indistinguishable between stereoisomers. By adding cholesterol to membranes, however, the membrane-disordering effects showed stereostructure-specificity that was enhanced with increasing the cholesterol content (0 to 15 mol%). The enantio-differentiating effects resulted from neither impurities in enantiomers nor hydrophobic interaction with phosphatidylcholine acyl chains. Bupivacaine disordered nerve cell model membranes with the potency being S(−)-enantiomer < racemate < R(+)-enantiomer, which resembled their relative stereopotency in nerve and cardiac channel inhibition. Membrane-disordering stereospecificity disappeared in the membranes without containing cholesterol. Conclusions: Bupivacaine stereostructure-specifically interacts with membranes containing cholesterol, which is consistent with the clinical features of S(−)-bupivacaine. Membrane cholesterol appears to increase the chirality of lipid bilayers and enable them to interact with S(−)-, racemic and R(+)-bupivacaine differently.

[1]  G. Strichartz,et al.  Tetracaine-membrane interactions: effects of lipid composition and phase on drug partitioning, location, and ionization. , 2007, Biophysical journal.

[2]  F. Severcan,et al.  Effect of progesterone on DPPC membrane: evidence for lateral phase separation and inverse action in lipid dynamics. , 2005, Archives of biochemistry and biophysics.

[3]  H. Tsuchiya,et al.  Reversed-phase liquid chromatographic retention and membrane activity relationships of local anesthetics. , 2005, Journal of chromatography. A.

[4]  A. Spisni,et al.  Differential effects of uncharged aminoamide local anesthetics on phospholipid bilayers, as monitored by 1H-NMR measurements. , 2005, Biophysical chemistry.

[5]  J. Daut,et al.  Enantioselective Actions of Bupivacaine and Ropivacaine on Coronary Vascular Resistance at Cardiotoxic Concentrations , 2005, Anesthesia and analgesia.

[6]  J. Martens,et al.  Localization of ion channels to lipid Raft domains within the cardiovascular system. , 2004, Trends in cardiovascular medicine.

[7]  A. Sia,et al.  A Comparison of Duration of Analgesia of Intrathecal 2.5 mg of Bupivacaine, Ropivacaine, and Levobupivacaine in Combined Spinal Epidural Analgesia for Patients in Labor , 2004, Anesthesia and analgesia.

[8]  G. B. Dawson,et al.  Cholesterol bonded phase as a separation medium in liquid chromatography. Evaluation of properties and applications. , 2003, Journal of chromatography. A.

[9]  H. Tsuchiya,et al.  Membrane effects of ropivacaine compared with those of bupivacaine and mepivacaine , 2002, Fundamental & clinical pharmacology.

[10]  R. Weiskopf,et al.  Drug Chirality in Anesthesia , 2002, Anesthesiology.

[11]  J. Heavner.  Cardiac Toxicity of Local Anesthetics in the Intact Isolated Heart Model: A Review , 2002, Regional Anesthesia & Pain Medicine.

[12]  H. Tsuchiya.  Structure‐Specific Membrane‐Fluidizing Effect Of Propofol , 2001, Clinical and experimental pharmacology & physiology.

[13]  H. Tsuchiya,et al.  Stereospecificity in membrane effects of catechins. , 2001, Chemico-biological interactions.

[14]  T. Nelson,et al.  Is Comparative Cardiotoxicity of S(−) and R(+) Bupivacaine Related to Enantiomer-Selective Inhibition of L-Type Ca2+ Channels? , 2001, Anesthesia and analgesia.

[15]  G. Strichartz,et al.  Potency of bupivacaine stereoisomers tested in vitro and in vivo: biochemical, electrophysiological, and neurobehavioral studies. , 2000, Anesthesiology.

[16]  A. Markham,et al.  Levobupivacaine , 2000, Drugs.

[17]  G. Hempelmann,et al.  Stereoselectivity of bupivacaine in local anesthetic-sensitive ion channels of peripheral nerve. , 1999, Anesthesiology.

[18]  G. Lyons,et al.  Epidural pain relief in labour: potencies of levobupivacaine and racemic bupivacaine. , 1998, British journal of anaesthesia.

[19]  R. Brown,et al.  Sphingolipid organization in biomembranes: what physical studies of model membranes reveal. , 1998, Journal of cell science.

[20]  I. Siafaka,et al.  Modulation of Synaptosomal Plasma Membrane-Bound Enzyme Activity Through the Perturbation of Plasma Membrane Lipid Structure by Bupivacaine , 1997, Anesthesia and analgesia.

[21]  R. Wallin,et al.  The duration of action of bupivacaine, levobupivacaine, ropivacaine and pethidine in peripheral nerve block in the rat , 1997, Acta anaesthesiologica Scandinavica.

[22]  G. Gimpl,et al.  Cholesterol as modulator of receptor function. , 1997, Biochemistry.

[23]  J. Tamargo,et al.  Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes. , 1995, Circulation.

[24]  J. Tamargo,et al.  Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers. , 1995, Biophysical journal.

[25]  K. Miller,et al.  Stereoselectivity of Channel Inhibition by Secondary Alkanol Enantiomers at Nicotinic Acetylcholine Receptors , 1993, Anesthesiology.

[26]  J. Månsson,et al.  Membrane lipids of human peripheral nerve and spinal cord. , 1992, Biochimica et biophysica acta.

[27]  G. Strichartz,et al.  Stereoselective inhibition of neuronal sodium channels by local anesthetics. Evidence for two sites of action? , 1992, Anesthesiology.

[28]  J. Butterworth,et al.  Molecular Mechanisms of Local Anesthesia: A Review , 1990, Anesthesiology.

[29]  E. Arnett,et al.  Stereoselective recognition in phospholipid monolayers. , 1988, Advances in experimental medicine and biology.

[30]  D. B. Goldstein,et al.  The effects of drugs on membrane fluidity. , 1984, Annual review of pharmacology and toxicology.